Biolife solutions reports fourth quarter and full year 2023 financial results

Fourth quarter cell processing revenue up 11% sequentially to $14.8 million, and positive adjusted ebitda of $700,000 expects 2024 revenue of $95.5 - $100.0 million excluding freezer business and positive adjusted ebitda conference call begins at 4:30 p.m. eastern time today bothell, wash.

BLFS Ratings Summary

BLFS Quant Ranking